Crossmark

Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy

Crossref DOI link: https://doi.org/10.1016/j.pharep.2017.01.007

Published Print: 2017-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

López-García, Miguel A.

Feria-Romero, Iris A.

Serrano, Héctor

Rayo-Mares, Darío

Fagiolino, Pietro

Vázquez, Marta

Escamilla-Núñez, Consuelo

Grijalva, Israel

Escalante-Santiago, David

Orozco-Suarez, Sandra
Funding

Funding for this research was provided by:

Institute of Science and Technology of GDF PIFUTP/08-127

National Council of Science and Technology (CONACYT) (248513)
License Information

Text and Data Mining valid from 2017-06-01
More Information

This article is maintained by: Elsevier

Article Title: Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy

Journal Title: Pharmacological Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharep.2017.01.007

Content Type: article

Copyright: © 2017 Published by Elsevier Sp. z o.o. on behalf of Institute of Pharmacology, Polish Academy of Sciences.